NORGESTIMATE AND ETHINYL ESTRADIOL Drug Patent Profile
✉ Email this page to a colleague
When do Norgestimate And Ethinyl Estradiol patents expire, and what generic alternatives are available?
Norgestimate And Ethinyl Estradiol is a drug marketed by Amneal Pharms, Glenmark Pharms Ltd, Glenmark Speclt, Lupin Ltd, Lupin Pharms, Mylan, Naari Pte Ltd, Watson Labs, and Xiromed. and is included in seventeen NDAs.
The generic ingredient in NORGESTIMATE AND ETHINYL ESTRADIOL is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORGESTIMATE AND ETHINYL ESTRADIOL?
- What are the global sales for NORGESTIMATE AND ETHINYL ESTRADIOL?
- What is Average Wholesale Price for NORGESTIMATE AND ETHINYL ESTRADIOL?
Summary for NORGESTIMATE AND ETHINYL ESTRADIOL
US Patents: | 0 |
Applicants: | 9 |
NDAs: | 17 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 29 |
Patent Applications: | 8 |
DailyMed Link: | NORGESTIMATE AND ETHINYL ESTRADIOL at DailyMed |
Recent Clinical Trials for NORGESTIMATE AND ETHINYL ESTRADIOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Benha University | Phase 2/Phase 3 |
Amgen | Phase 1 |
Gilead Sciences | Phase 1 |